Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 161 ~ 180 of 25905, Page 9 of 1296
161. Understanding Cancer Death Rates
Cancer death rates are one of the most important measures researchers use to track progress against cancer. American Cancer Society researchers report on cancer death rates annually in the publication, Cancer Facts & Figures. This article explains what a death rate is and when researchers use it.
01/25/2019 American Cancer Society
162. Statement from FDA Commissioner and director of the Center for Drug Evaluation and Research on the FDA’s ongoing investigation into valsartan and ARB class impurities and the agency’s steps to address the root causes of the safety issues
163. RSNA in Brief-Q4 2018
To keep media informed about its current activities, the Radiological Society of North America (RSNA) distributes brief quarterly updates. For more information about any of these activities or to interview a spokesperson, contact RSNA Media Relations staff.
01/24/2019 Radiological Society of North America
164. FDA statement from Commissioner announcing efforts to improve the quality of the information used to assess the effectiveness of REMS programs in supporting the safe use of medications
Risk Evaluation and Mitigation Strategy (REMS)
165. Lung Cancer Screening Guidelines for Current or Former Smokers
American Cancer Society guidelines recommend yearly lung cancer screening for people who meet certain criteria that put them at higher risk for developing the disease.
01/24/2019 American Cancer Society
166. Medtronic to Acquire EPIX Therapeutics, Expanding Its Cardiac Ablation Portfolio
DiamondTemp Ablation System Represents Disruptive RF Innovation
01/24/2019 Medtronic
167. Abbott Reports 2018 Results and Issues Strong Forecast for 2019
Full-year 2018 sales growth of 11.6 percent; organic sales growth of 7.3 percent / Issues financial outlook for 2019, reflecting double-digit EPS growth and 6.5 to 7.5 percent organic sales growth
01/23/2019 Abbott
168. Statement from FDA Commissioner, Director of the Center for Devices and Radiological Health, on latest steps to strengthen FDA’s 510(k) program for premarket review of medical devices
169. Artificial Intelligence Shows Potential for Triaging Chest X-rays
Researchers trained an artificial intelligence system to interpret and prioritize abnormal chest X-rays with critical findings. / Chest X-rays account for 40 percent of all diagnostic imaging worldwide and create significant backlogs at health care facilities. / The AI system distinguished abnormal from normal X-rays with high accuracy.
01/22/2019 Radiological Society of North America
170. U.S. FDA Accepts sNDAs for PIFELTRO™ (doravirine) and DELSTRIGO™ (doravirine/lamivudine/tenofovir disoproxil fumarate)
Potential New Indication Would Expand Use to Allow Treatment-Experienced Adults Living with HIV-1 Whose Virus is Suppressed to Switch to PIFELTRO (in Combination with Other Antiretrovirals) or DELSTRIGO
01/22/2019 MERCK
171. Patient-Level Survival Analysis Demonstrates No Link Between Paclitaxel Dose and Mortality in Patients Treated with IN.PACT Admiral DCB
Data Presented Today at LINC Reiterate Commitment to Patient Safety and Data Transparency
01/22/2019 Medtronic
172. Study: Oncologists Want More Education About LGBTQ Issues
A survey of oncologists finds that most say they don’t know enough about how to treat people in the lesbian, gay, bisexual, transgender, and queer/questioning (LGBTQ) community, but want to learn more.
01/22/2019 American Cancer Society
173. Trampoline parks may cause more severe trauma than at home trampoline use
New research compares injuries sustained at commercial jump parks versus home trampolines
01/22/2019 American Academy of Orthopaedic Surgeons
174. Lifestyle Choices May Help Glaucoma Patients Preserve Eyesight
American Academy of Ophthalmology offers advice on how people can take control of their health beyond medications and surgery
01/22/2019 American Academy of Ophthalmology
175. Abbott Offers a New Option for Physicians Treating Patients with Atrial Fibrillation
With approval of the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™, Abbott is helping more physicians integrate ablation with 3D mapping to advance the treatment of people with atrial fibrillation
01/21/2019 Abbott
176. New Data Reinforce Benefits of Abbott’s BurstDR™ Spinal Cord Stimulation for People Living with Chronic Pain
Data from two recent studies presented at NANS 2019 demonstrate key benefits of BurstDR™ stimulation / Microdosing BurstDR stimulation at lowest effective energy allows patients to manage their pain without the burden of recharging their devices / Additional data further showed switching from other types of SCS therapies to Abbott’s BurstDR stimulation significantly reduced pain and the need for opioid medication
01/19/2019 Abbott
177. ACS Cancer Prevention Blueprint Targets Controllable Risk Factors
This second chapter in the American Cancer Society Cancer Control Blueprint describes what we know about risk factors for cancer. It provides strategies people can use to help avoid those risk factors. It also offers strategies that cities, states, and communities can use to help people avoid them. It''s co-authored by staff researcher Susan Gapstur, PhD, MPH, senior vice president of Behavioral and Epidemiology Research.
01/18/2019 American Cancer Society
178. American Academy of Orthopaedic Surgeons approves clinical practice guideline for management of acute compartment syndrome
Evidence-based diagnosis and treatment recommendations for traumatic, severe limb injuries
01/17/2019 American Academy of Orthopaedic Surgeons
179. Statement from FDA Commissioner, on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths
180. World Cancer Day 2019: ‘I Am and I Will.’
Monday, February 4th is World Cancer Day, when organizations and people around the world unite to raise awareness about cancer and work to make it a global health priority.
01/17/2019 American Cancer Society
1 2 3 4 5 6 7 8 9 10
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱